Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery (Q34350615)

1 August 2017

Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery (English)

1 reference

1 August 2017

0 references

1 reference

6

1 reference

1 August 2017

Francesca Pentimalli

3

0 references

Giulio Tarro

series ordinal

5

object named as

Giulio Tarro

1 reference

1 August 2017

1

Paola Indovina

1 reference

1 August 2017

2

Eleonora Marcelli

1 reference

1 August 2017

Piero Tanganelli

4

1 reference

1 August 2017

24 July 2012

1 reference

Mass Spectrometry Reviews

1 August 2017

1 reference

1 August 2017

32

1 reference

1 August 2017

129-142

1 reference

1 August 2017

2

1 reference

Proteomic analysis of lung biopsies: Differential protein expression profile between peritumoral and tumoral tissue

1 August 2017

1 reference

Glycomics and disease markers

21 January 2018

1 reference

Deep proteome profiling of sera from never-smoked lung cancer patients.

21 January 2018

1 reference

Distribution of alpha-1-antitrypsin and haptoglobin phenotypes in bladder cancer patients

21 January 2018

1 reference

Overexpression of the stathmin gene in a subset of human breast cancer

21 January 2018

1 reference

Serum amyloid A (SAA) variations in patients with cancer: correlation with disease activity, stage, primary site, and prognosis

21 January 2018

1 reference

Correlation of oncoprotein 18/stathmin expression in human breast cancer with established prognostic factors

21 January 2018

1 reference

Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors

21 January 2018

1 reference

Protein profiles associated with survival in lung adenocarcinoma

21 January 2018

1 reference

Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis

21 January 2018

1 reference

Overexpression of stathmin in breast carcinomas points out to highly proliferative tumours

21 January 2018

1 reference

Incorporating bortezomib into the treatment of lung cancer

21 January 2018

1 reference

Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer

21 January 2018

1 reference

Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?

21 January 2018

1 reference

Biomarker discovery and identification from non-small cell lung cancer sera

21 January 2018

1 reference

S100 proteins and their influence on pro-survival pathways in cancer

21 January 2018

1 reference

Improved diagnosis of pancreatic adenocarcinoma using haptoglobin and serum amyloid A in a panel screen.

21 January 2018

1 reference

Differentiation-stage specific expression of oncoprotein 18 in human and rat prostatic adenocarcinoma.

21 January 2018

1 reference

MALDI profiling of human lung cancer subtypes.

21 January 2018

1 reference

Systemic disease-induced salivary biomarker profiles in mouse models of melanoma and non-small cell lung cancer

21 January 2018

1 reference

The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5.

21 January 2018

1 reference

Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma

21 January 2018

1 reference

Current two-dimensional electrophoresis technology for proteomics

21 January 2018

1 reference

An overview of lung cancer genomics and proteomics

21 January 2018

1 reference

Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence

21 January 2018

1 reference

Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.

21 January 2018

1 reference

Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry

21 January 2018

1 reference

Identification of candidate molecular markers predicting chemotherapy resistance in non-small cell lung cancer

21 January 2018

1 reference

Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.

21 January 2018

1 reference

Proteomics: current techniques and potential applications to lung disease

21 January 2018

1 reference

Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis

21 January 2018

1 reference

Improving Detection Accuracy of Lung Cancer Serum Proteomic Profiling via Two-Stage Training Process

21 January 2018

1 reference

Human saliva proteome analysis and disease biomarker discovery

21 January 2018

1 reference

21 January 2018

Cancer statistics, 2009

1 reference

S100A6 (calcyclin) enhances the sensitivity to apoptosis via the upregulation of caspase-3 activity in Hep3B cells

21 January 2018

1 reference

The Haptoglobin β chain as a supportive biomarker for human lung cancers.

21 January 2018

1 reference

Proteomics analysis in lung cancer: challenges and opportunities

21 January 2018

1 reference

Lung cancer proteomics, clinical and technological considerations

21 January 2018

1 reference

Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma

21 January 2018

1 reference

Proteasome inhibition and its clinical prospects in the treatment of hematologic and solid malignancies

21 January 2018

1 reference

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

Proteomic analysis of stage I primary lung adenocarcinoma aimed at individualisation of postoperative therapy

21 January 2018

1 reference

Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery

21 January 2018

1 reference

Peptide and protein imaging mass spectrometry in cancer research

21 January 2018

1 reference

Enriched sera protein profiling for detection of non-small cell lung cancer biomarkers

21 January 2018

1 reference

Mass spectrometry in high-throughput proteomics: ready for the big time.

21 January 2018

1 reference

Mass spectrometry-based proteomic profiling of lung cancer

21 January 2018

1 reference

A database of protein expression in lung cancer

21 January 2018

1 reference

Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma.

21 January 2018

1 reference

Catabolism of hemoglobin-haptoglobin complex in microsome subfractions

21 January 2018

1 reference

Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.

21 January 2018

1 reference

Panel of serum biomarkers for the diagnosis of lung cancer.

21 January 2018

1 reference

Use of narrow-range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion

21 January 2018

1 reference

Overexpression of sorcin in multidrug resistant human leukemia cells and its role in regulating cell apoptosis.

21 January 2018

1 reference

Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer

21 January 2018

1 reference

Proteomic patterns of preinvasive bronchial lesions

21 January 2018

1 reference

Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer

21 January 2018

1 reference

Characterization of Listeria monocytogenes recovered from imported cheese contributed to the National PulseNet Database by the U.S. Food and Drug Administration from 2001 to 2008.

21 January 2018

1 reference

Classification by mass spectrometry can accurately and reliably predict outcome in patients with non-small cell lung cancer treated with erlotinib-containing regimen

21 January 2018

1 reference

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

21 January 2018

1 reference

Identification of serum biomarkers for lung cancer using magnetic bead-based SELDI-TOF-MS.

21 January 2018

1 reference

Advancing cancer biotherapy with proteomics

21 January 2018

1 reference

Biomarkers for the lung cancer diagnosis and their advances in proteomics

21 January 2018

1 reference

Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer.

21 January 2018

1 reference

Lung cancer signatures in plasma based on proteome profiling of mouse tumor models

21 January 2018

1 reference

Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study.

21 January 2018

1 reference

21 January 2018

1 reference

Phosphoglycerate kinase 1-overexpressing lung cancer cells reduce cyclooxygenase 2 expression and promote anti-tumor immunity in vivo

21 January 2018

1 reference

Early diagnosis of lung cancer by detection of tumor liberated protein

21 January 2018

1 reference

Tumor liberated protein from lung cancer and perspectives for immunotherapy

21 January 2018

1 reference

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis

21 January 2018

1 reference

Glycosylation changes as markers for the diagnosis and treatment of human disease.

21 January 2018

1 reference

Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer

21 January 2018

1 reference

Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays

21 January 2018

1 reference

Serum amyloid A, the major vertebrate acute-phase reactant

21 January 2018

1 reference

Differential exoprotease activities confer tumor-specific serum peptidome patterns

21 January 2018

1 reference

Prediction of outcome of non-small cell lung cancer patients treated with chemotherapy and bortezomib by time-course MALDI-TOF-MS serum peptide profiling

21 January 2018

1 reference

Differential analysis of two-dimension gel electrophoresis profiles from the normal-metaplasia-dysplasia-carcinoma tissue of human bronchial epithelium

21 January 2018

1 reference

Development of proteomic patterns for detecting lung cancer

21 January 2018

1 reference

14-kDa phosphohistidine phosphatase and its role in human lung cancer cell migration and invasion

21 January 2018

1 reference

MALDI-MS derived prognostic protein markers for resected non-small cell lung cancer

21 January 2018

1 reference

Proteomic patterns of tumour subsets in non-small-cell lung cancer

21 January 2018

1 reference

A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer.

21 January 2018

1 reference

Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection

21 January 2018

1 reference

Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.

21 January 2018

1 reference

Update on nonsmall cell lung cancer

21 January 2018

1 reference

Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry

21 January 2018

1 reference

Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer

21 January 2018

1 reference

AZGP1 mRNA levels in normal human lung tissue correlate with lung cancer disease status

21 January 2018

1 reference

Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MAS.21355

1 reference

1 August 2017

1 reference

PubMed ID

22829143